Insider Transactions Reported by 17 Insiders of Outlook Therapeutics, Inc.

Symbol
OTLK on Nasdaq
Location
Iselin, NJ

There are no Buy or Sell transactions made by insiders since 07 Jan 2025

Outlook Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Arun Pillai Director, 10%+ Owner $26,085,170 01 Feb 2022
Tenshi Healthcare Pte. Ltd. 10%+ Owner $26,085,170 21 Apr 2022
Ghiath M. Sukhtian Director, 10%+ Owner $18,973,302 27 May 2025
Terry Dagnon Chief Operations Officer $741,221 20 Apr 2023
Syntone Ventures LLC 10%+ Owner $716,284 15 Apr 2024
Jeff Evanson Chief Commercial Officer $339,553 20 Mar 2024
LAWRENCE KENYON Chief Financial Officer, Director $33,828 26 Sep 2024
Julian S. Gangolli Director 01 Oct 2025
RANDY H. THURMAN Director 01 Oct 2025
C. RUSSELL TRENARY III CEO AND PRESIDENT, Director 20 Mar 2024
Robert Jahr Chief Executive Officer 01 Jul 2025
Julia A. Haller Director 01 Oct 2025
Gerd Auffarth Director 01 Oct 2025
Faisal Ghiath Sukhtian Director 01 Oct 2025
Yezan Munther Haddadin Director 01 Oct 2025
Andong Huang Director 01 Oct 2025
KURT J. HILZINGER Director 01 Oct 2025

Recent Insider Transactions by Companies or Individuals for Outlook Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.